RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Senthilnath Lakshmana Chetty, PhD
2020
$ 30,000
Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation
Breelyn Wilky, MD & Eduardo Davila, PhD
2020
$ 60,000
Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma
Zachary Graff, MD
2020
$ 30,000
Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia
Christine Towers, PhD
2020
$ 30,000
Identifying novel regulators of mitochondrial turn over
Paula Jedlicka, MD, PhD
2020
$ 30,000
Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma
Zdenek Andrysik PhD
2020
30,000
Exploring strong synergism of targeted p53 activation and translation inhibition in colorectal cancer.
Matthew Tallaferro, PhD
2020
$ 30,000
Control of cell division through centrosomal RNA localization
Ryan Marker, PhD
2020
$ 30,000
Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors
Diana M. Cittelly, PhD
2020
$ 30,000
Function of Ephrin B Signaling in Breast cancer brain metastasis
Molishree Joshi, PhD
2020
$ 30,000
A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD
2020
$ 60,000
Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells
Swati G. Patel, MD, MS
2020
$ 30,000
Identification of Hereditary Cancer Syndromes through Advanced Polyps
Rebecca Schweppe, PhD
2020
$ 30,000
The role of Nuclear FAK in Thyroid Cancer
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD
2020
$ 60,000
The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD
2020
$ 60,000
The role of alpha-1 antitrypsin in cancer immunotherapy
Maureen Lynch, Phd & Philip Owens, PhD
2020
$ 60,000
The role of exercise in breast cancer bone metastasis
Isabel Schlaepfer, PhD
2019
$ 30,000
Role of fat oxidation via CPT1A in immunological response to prostate cancer
Rajeev Vibhakar, MD, PhD, MPH
2019
$ 30,000
Role of CDK7 in medulloblastoma
Jay Hesselberth, PhD
2019
$ 30,000
Single-cell methods to measure functional heterogeneity
John Tentler, PhD
2019
$ 30,000
Cancer Research Summer Fellowship Program
Matthew Sikora, PhD
2019
$ 30,000
Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma
Zachary Levi Watson, PhD
2019
$ 30,000
Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer
Stephen Keysar, PhD
2019
$ 30,000
Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation
Cem Altunbas, PhD
2019
$ 30,000
High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy
Yiqun Shellman, PhD & Martin McCarter, MD
2019
$ 60,000
Targeting anti-apoptotic pathways to improve immunotherapies for melanoma
Paul Norman, PhD
2019
$ 30,000
Natural Killer cells can protect from developing leukemia
Heather Brechbuhl, PhD
2019
$ 30,000
Defining reversible tumor traits in the obese microenvironment
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD
2019
$ 60,000
Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
2019
$ 60,000
Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy
Mayumi Fujita, MD, PhD & Donald Backos, PhD
2019
$ 60,000
Somatic mutations in inflammasome genes in melanoma
Neil Box, PhD
2019
$ 30,000
Regulation of p53 in tanning
Carol Sartorius, PhD
2019
$ 30,000
PR-RAR downregulation of protein synthesis and cell growth in breast cancer
Adam Mueller, MD, PhD
2019
$ 30,000
Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD
2019
$ 60,000
CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG
Jill Slansky PhD
2018
$ 30,000
Functional activation of low-affinity T cells in the tumor
Adwitiya Kar, PhD and Margaret Wierman, MD
2018
$ 30,000
Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma
Maria Jose Contreras, PhD
2018
$ 30,000
Mechanisms of TDM1/radiation-induced toxicity in brain metastases
John Tentler, PhD
2018
$ 30,000
Cancer Research Summer Fellowship Program
Mair E.A. Churchill, PhD
2018
$ 30,000
Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis
Courtney Jones, PhD
2018
$ 30,000
Targeting relapse leukemia stem cells through inhibition of NAD synthesis
Linda Van Dyk, PhD
2018
$ 30,000
Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis
Nicholas Forman, MD
2018
$ 30,000
Characterization of heterogeneous tumor subpopulations in childhood ependymoma
Zhangguo Chen, PhD
2018
$ 30,000
Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy
Nathan Dahl, MD
2018
$ 30,000
Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma
Christopher Lieu, MD and Todd Pitts, MD
2018
$ 60,000
Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer
Jennifer DeLuca, PhD
2018
$ 30,000
Targeting Kinetochore Dysfunction in Cancer Cells
Raul M. Torres, PhD
2018
$ 30,000
Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid
Rebecca Schweppe, PhD
2018
$ 30,000
Cooperative Src and MAP Kinase Signaling in Thyroid Cancer
David Thomas, PhD and Mark Borden, PhD
2018
$ 30,000
X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy
Benjamin Bitler, PhD
2018
$ 30,000
Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance
David Ryan Ormond MD
2018
$ 30,000
Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD
2018
$ 60,000
Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma
Martin McCarter, MD
2018
$ 30,000
Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function
Jessica Lake, MD, MPH
2018
$ 30,000
IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas
Scott Cramer, PhD and James Costello, PhD
2018
$ 60,000
Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7
Jennifer Hintzsche, PhD
2018
$ 30,000
Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer
Britta Jacobsen, PhD
2017
30,000
Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer
Jing H. Wang, MD, PhD
2017
30,000
Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses
Matthew J. Sikora, PhD
2017
30,000
Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma
Traci R. Lyons, PhD and Beth Taburini, PhD
2017
60,000
Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity
Eric Clambey, PhD
2017
30,000
High-dimensional analysis of effector T cell mechanisms in lung cancer
David Bentley, PhD
2017
30,000
Deregulation of mRNA 3′ end formation in breast cancer
Rebecca Schweppe, PhD
2017
30,000
Targeting FAK and Src in Thyroid Cancer
Todd Hankinson, MD, MBA
2017
27,976
Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression
Dan Theodorescu, MD, PhD
2017
30,000
Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients
Amanda C. Winters, MD, PhD
2017
30,000
Validating CD123 as a Leukemia Stem Cell Marker and Therapeutic Target in Pediatric AML
James Costello, PhD
2017
30,000
Measuring chromosome-conformation abnormalities within a single cancer cell
Jenna Sopfe, MD
2017
29,961
Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population
Jung-Jae Lee, PhD
2017
29,835
Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer
Heide L. Ford, PhD
2017
30,000
Role of Six2 in mediating late stage metastasis
Hyunmin Kim, PhD
2017
30,000
Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer
Changwei Liu, PhD
2017
30,000
Validating USP35 as an anticancer drug target
Darinee Tippimanchai, PhD
2017
30,000
Targeting IL17 in Kras mutant lung cancer
James DeGregori, PhD
2017
30,000
Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer
John Tentler, PhD
2017
30,000
Cancer Research Summer Fellowship Program